These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 4445568)

  • 1. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
    Moody DE; Reddy JK
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):501-10. PubMed ID: 4445568
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic microbody proliferation and catalase synthesis induced by methyl clofenapate, a hypolipidemic analog of CPIB.
    Reddy JK
    Am J Pathol; 1974 Apr; 75(1):103-18. PubMed ID: 4825610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes.
    Moody DE; Reddy JK
    Am J Pathol; 1978 Feb; 90(2):435-46. PubMed ID: 623209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.
    Reddy J; Svoboda D; Azarnoff D
    Biochem Biophys Res Commun; 1973 May; 52(2):537-43. PubMed ID: 4711169
    [No Abstract]   [Full Text] [Related]  

  • 5. Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in response.
    Reddy JK; Azarnoff DL; Svoboda DJ; Prasad JD
    J Cell Biol; 1974 May; 61(2):344-58. PubMed ID: 4208071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the hepatic microbody membrane in freeze-fracture replicas.
    Reddy JK; Tewari JP; Svoboda DJ; Malhotra SK
    Lab Invest; 1974 Sep; 31(3):268-75. PubMed ID: 4413769
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic catalase is not essential for the hypolipidemic action of peroxisome proliferators.
    Reddy JK; Moody DE; Azarnoff DL; Rao MS
    Proc Soc Exp Biol Med; 1977 Apr; 154(4):483-7. PubMed ID: 859854
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible properties of microbodies (peroxisomes). Microbody proliferation and hypolipidemic drugs.
    Reddy JK
    J Histochem Cytochem; 1973 Nov; 21(11):967-71. PubMed ID: 4587529
    [No Abstract]   [Full Text] [Related]  

  • 9. Carnitine octanoyltransferase of mouse liver peroxisomes: properties and effect of hypolipidemic drugs.
    Farrell SO; Bieber LL
    Arch Biochem Biophys; 1983 Apr; 222(1):123-32. PubMed ID: 6838215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of administration of clofibrate and clofenapate on the content and distribution of ubiquinone in rat tissues.
    Krishnakantha TP; Kurup CK
    Indian J Biochem Biophys; 1974 Mar; 11(1):51-3. PubMed ID: 4435808
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of administration of clofibrate and clofenapate on the activities of glycerolphosphate dehydrogenase and catalase in rat kidney mitochondria.
    Krishnakantha TP; Kurup CK
    Indian J Biochem Biophys; 1973 Sep; 10(3):224-7. PubMed ID: 4792935
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of peroxisome proliferating hypolipidemic agents on serum activity levels of arylesterase and cholinesterase in rats and mice.
    Butler EG; England PJ; Williams GM
    Res Commun Chem Pathol Pharmacol; 1988 Apr; 60(1):125-8. PubMed ID: 3381006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential increase of hepatic peroxisomal, mitochondrial and microsomal carnitine acyltransferases in clofibrate-fed rats.
    Markwell MA; Bieber LL; Tolbert NE
    Biochem Pharmacol; 1977 Sep; 26(18):1697-702. PubMed ID: 901588
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of selected hypolipidemic drugs on cell ultrastructure.
    Svoboda DJ; Azarnoff DL
    Fed Proc; 1971; 30(3):841-7. PubMed ID: 5575296
    [No Abstract]   [Full Text] [Related]  

  • 15. Interlobular differences in the changes induced in rat liver by clofibrate and clofenapate.
    Krishnakantha TP; Kurup CK
    Environ Physiol Biochem; 1974; 4(5):243-50. PubMed ID: 4461276
    [No Abstract]   [Full Text] [Related]  

  • 16. A kinetic comparison of the physiological effects of clofibrate and clofenapate in the rat.
    Krishnakantha TP; Kurup CK
    Environ Physiol Biochem; 1974; 4(2):80-8. PubMed ID: 4459126
    [No Abstract]   [Full Text] [Related]  

  • 17. Stimulation of catalase synthesis and increase of carnitine acetyltransferase activity in the liver of intact female rats fed clofibrate.
    Reddy JK; Kumar NS
    J Biochem; 1979 Mar; 85(3):847-56. PubMed ID: 429267
    [No Abstract]   [Full Text] [Related]  

  • 18. [Peroxisomes and hypolipidemic agents ].
    Heller F; Pourbaix S
    Sem Hop; 1982 Jul; 58(28-29):1712-7. PubMed ID: 6289453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays.
    Warren JR; Simmon VF; Reddy JK
    Cancer Res; 1980 Jan; 40(1):36-41. PubMed ID: 6765917
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of the hypolipidemic drug nafenopin (2-methyl-2-(p-(1,2,3,4-tetrahydro-1-naphthyl)phenoxy)propionic acid; TPIA; SU-13,437), on the hepatic disposition of foreign compounds in the rat.
    Levine WG
    Drug Metab Dispos; 1974; 2(2):178-86. PubMed ID: 4150998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.